Co-Authors
This is a "connection" page, showing publications co-authored by AUNG NAING and BEHRANG AMINI.
Connection Strength
0.251
-
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study. Cancer. 2022 09 15; 128(18):3383-3391.
Score: 0.214
-
First-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patients. JCI Insight. 2017 Apr 20; 2(8).
Score: 0.037